ArticleJournal of experimental & clinical cancer research : CR2022

Targeting CRABP-II overcomes pancreatic cancer drug resistance by reversing lipid raft cholesterol accumulation and AKT survival signaling.

Shuiliang Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.